Lung cancer, genetic profile to choose better treatments

In oncology, genomic profiling makes it possible to trace the genetic-molecular profile of the various tumor forms, giving the possibility of treating patients with personalized therapies, with positive impacts on the duration and quality of life.

    NGS technologies, allowing the simultaneous evaluation of various alterations, also play a key role in lung cancer, which in Italy represents the third most frequent neoplasm and the first cause of cancer death, with almost 34,000 deaths every year.

    Studies have shown how profiling by NGS for some lung cancers (non-small cell), determines an important reduction in expenditure per patient tested compared to the use of standard techniques; despite this, in our country, patients' access to genetic tests is still limited and suffers from high regional variability.

    In the digital event, created by

, the prospects for lung cancer patients will be discussed. how to facilitate patients' access to diagnostic tests and innovative therapies and the contribution that institutions can offer.

    The digital event will be attended by: Mauro Biffoni - Director of the Oncology and Molecular Medicine Department, Higher Institute of Health Paola Binetti - Member of the Hygiene and Health Commission, Senate Giorgio Clarotti - Senior Policy Officer for Health, European Commission Vito De Filippo - Member of the Social Affairs Commission , Chamber of Deputies Massimo Di Maio - Secretary, AIOM Renato Franco - Coordinator of the Italian Group for the Study of Pleuro-Pulmonary Pathology, Italian Society of Pathological Anatomy and Diagnostic Cytopathology Antonio Gaudioso - President, Cittadinanzattiva; Member of the LEA Commission, Ministry of Health Stefania Gori - President,ROPI - Italian Patient Oncology Network and AIOM Foundation Carmine Pinto - President of the Federation of Italian Cooperative Oncology Groups (FICOG) Maria Rizzotti - Member of the Hygiene and Health Commission, Senate Marcello Tiseo - Head of the Unit of Complex Oncology Outpatient Activities and PTDA Coordinator of Thoracic Oncology , AOU Parma.